Antibacterial effect of fermented milk containing Bifidobacterium breve, Bifidobacterium bifidum and Lactobacillus acidophilus against indigenous Escherichia coli infection in mice

Microbial Ecology in Health and Disease

Volumn 13, Issue 1, 2001, Pages 16-24

  Asahara, T ^a   Shimizu, K ^a   Nomoto, K ^a   Watanuki, M ^a   Tanaka, R ^a  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Acetic acid; Bifidobacteria; E. coli; Fermented milk; Infection; Mouse; Short chain fatty acid (SCFA)

Indexed keywords

ACETIC ACID; FLUOROURACIL; SHORT CHAIN FATTY ACID; WATER; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BODY WEIGHT; CONTROLLED STUDY; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; IN VITRO STUDY; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; MALE; MILK; MOUSE; NONHUMAN; NUTRITION; PH; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALIA; BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; ESCHERICHIA COLI; LACTOBACILLUS ACIDOPHILUS; NEGIBACTERIA;

EID: 0035086246     PISSN: 0891060X     EISSN: None     Source Type: Journal    
DOI: 10.1080/089106001750071663     Document Type: Article

References (49)

1. High dose combination chemotherapy for acute non-lymphoblastic leukemia in adults
2. A 4-year experience with anthracycline, cytosine, arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukopenia
3. Gram-negative bacteremia. Reassessment of etiology, epidemiology and ecology in 612 patients
4. Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies
5. The importance of surveillance stool culture during periods of severe neutropenia
6. Outcomes of bacteremia in patients with cancer and neutropenia: Observations from two decades of epidemiological and clinical trials
7. Management of fever in patients with cancer and treatment-induced neutropenia
8. Induction of lethal infection with indigenous Escherichia coli in mice by fluorouracil
9. Emergence of fluoroquinolon-resistant Escherichia coli at a cancer center
10. Considerations for the prevention of infectious complications in patients with cancer
11. Prevention of infection in the neutropenic patient
12. Incidence of trimethoprim-sul-famethoxazole-resistant Enterobacteriaceae among transplant recipients
13. Effect of a Lactobacillus product administration on the anaerobic intestinal flora of aged adults
14. Alteration of fecal bacterial flora following oral administration of bifidobacterial preparation
15. The effect of Bifidobacterium administration in patients with leukemia
16. Prophylaxis against ampicillin-associated diarrhea with a Lactobacillus preparation
17. Clinical effects of bifidobacterium preparations on pediatric intractable diarrhea
18. A human Lactobacillus strain (Lactobacillus casei sp. strain GG) promotes recovery from acute diarrhea in children
19. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG
20. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis
21. Selection and maintenance of probiotic strains
22. Lactic acid bacteria in health and disease
23. Colistin-oxolinic acid-blood agar. A new selective medium for streptococci
24. Collaborative study of an improved method for the enumeration and confirmation of Clostridium perfringens in foods
25. Isolation and identification of Bifidobacterium from feces of experimental rats: Species identification and preparation of improved selective medium
26. Selective agar medium for counting viable cells of bifidobacteria in fermented milk
27. Specific detection and analysis of a probiotic Bifidobacterium strain in infant feces
28. Correlation between water-holding capacity of different types of cellulose in vitro and gastrointestinal retention time in vivo of rats
29. Intestinal microbial ecology and its modulation under the influence of immunodepressants (Russian)
30. Interactions between Bifidobacterium bifidum N4 and Escherichia coli K-2 in their mixed cultures
31. The influence of pH, temperature and organic acids on the initiation of growth of Yersinia enterocolitica
32. Growth and survival kinetics of Yersinia enteroeolitica IP 383 0:9 as affected by equimolar concentrations of undissociated short-chain organic acids
33. Antibacterial action of vinegar against food-borne pathogenic bacteria including Escherichia coli O157:H7
34. Inhibition of enterobacteria and Listeria growth by lactic, acetic and formic acids
35. Relationship of volatile components and bacterial flora in mouse caecum
36. Effects of fecal microorganisms and their chloroform resistant variants derived from mice, rats, and humans on immunological and physiological characteristics of the intestines of ex-germfree mice
37. Protective effect of bifidus milk on the experimental infection with Salmonella enteritidis subsp. typhimurium in conventional and gnotobiotic mice
38. Enhancement of immune response in Peyer's patch cells cultured with Bifidobacterium breve
39. Detection of Bifidobacterium strains that induce large quantities of IgA
40. Augmentation of anti-influenza virus hemagglutinin antibody production by Peyer's patch cells with Bifidobacterium breve YIT 4064
41. Passive protection against rotavirus-induced diarrhea of mouse pups born to and nursed by dams fed Bifidobacterium breve YIT4064
42. Inhibition of Shigella sonnei by Lactobacillus casei and Lact. acidophilus
43. Prevention of gastrointestinal infection using immunobiological methods with milk fermented with Lactobacillus casei and Lactobacillus acidophilus
44. Prevention of indigenous infection of mice with Escherichia coli by nonspecific immunostimulation
45. Current probiotics-safety assured?
46. Demonstration of safety of probiotics-a review
47. The effect of Bifidobacterium breve administration on Campylobacter enteritis
48. Early administration of Bifidobacterium breve to preterm infants: Randomised controlled trial